Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells

BACKGROUNDS: Tamoxifen is typically used to treat patients with estrogen receptor alpha (ERα)-positive breast cancer. However, 30% of these patients gain acquired resistance to tamoxifen during or after tamoxifen treatment. As a Ras modulator, Nogo-B receptor (NgBR) is required for tumorigenesis thr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Breast Cancer Res
Main Authors: Gao, Pin, Wang, Xiang, Jin, Ying, Hu, Wenquan, Duan, Yajun, Shi, Aiping, Du, Ye, Song, Dong, Yang, Ming, Li, Sijie, Han, Bing, Zhao, Gang, Zhang, Hongquan, Fan, Zhimin, Miao, Qing Robert
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2018
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6134690/
https://ncbi.nlm.nih.gov/pubmed/30208932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-018-1028-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares